🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objectives: Specific Aim 1: To demonstrate the feasibility of using a Stea...
Status
Terminated
Location
University of Michigan Health System
Start Date
2017-03-01
Trial ID
NCT02791425
Treatments Being Tested
: CP is a neurodevelopmental condition. A set of irreversible impairments o...
Status
Completed
Location
Hafiza Shabnum Noor
Start Date
2022-08-16
Trial ID
NCT05792709
Treatments Being Tested
This Phase II Small Business Technology Transfer Research (STTR) will deliv...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2018-02-19
Trial ID
NCT02921776
Background: GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-19
Trial ID
NCT03952637
Treatments Being Tested
There is a considerable number children who are unable to speak, and our cu...
Status
Completed
Location
Riphah Child Development Centre & Step to Learn School
Start Date
2020-01-01
Trial ID
NCT04583332
Treatments Being Tested
Our aim in this prospective study is to evaluate the validity of the non-co...
Status
Recruiting
Location
Assuit university
Start Date
2025-12-01
Trial ID
NCT05783271
Treatments Being Tested
Many people with autism and other developmental conditions have difficulty ...
Status
Not Yet Recruiting
Location
University of Virginia
Start Date
2027-06-01
Trial ID
NCT07581483
Treatments Being Tested
My aim of the research is to compare the effect of traditional therapy with...
Status
Completed
Location
Special Education Academy
Start Date
2024-05-06
Trial ID
NCT06407349
Treatments Being Tested
The goal of this clinical trial is to learn if speech supplementation can i...
Status
Recruiting
Location
University of Wisconsin-Madison Waisman Center
Start Date
2026-07-27
Trial ID
NCT07173049
Treatments Being Tested